A conflict of interest may exist when an author (or the author's institution or employer) has financial or personal relationships or affiliations that could influence the author's decisions or work on the manuscript. Authors are required to identify all relevant financial interests and relationships or financial conflicts (e.g., employment/affiliation, grants or funding, consultancies, stock ownership or options, royalties, or patents filed, received, or pending), particularly those present at the time the research was conducted and through publication, as well as other financial interests that represent potential future financial gain. The disclosure of funding should be indicated in the “Acknowledgments” section within the manuscript.
The Copyright Agreement&Acknowledgement of Authorship Form should be completed by the corresponding author on behalf of each coauthor and should be submitted with the manuscript.
All submissions are screened by a similarity detection software (iThenticate) and the limitation without similarity is 20%.
The Editorial Board of Endourology Bulletin will immediately reject a submitting manuscript which has a high similarity index to other papers in the Similarity Check. When malpractices are found in the submitted article to Endourology Bulletin, Endourology Bulletin will follow the flowchart by the Committee on Publication Ethics (COPE) for settlement of any misconduct.
The Editorial Board of the journal handles all appeal and complaint cases within the scope of Committee on Publication Ethics (COPE) guidelines. In such cases, authors should get in direct contact with the editorial office regarding their appeals and complaints. When needed, an ombudsperson may be assigned to resolve cases that cannot be resolved internally. The Editor in Chief is the final authority in the decision-making process for all appeals and complaints.
The Editorial Board of Endourology Bulletin is always willing to publish corrections, clarifications, retractions when needed.
• For manuscripts concerning experimental research on humans, a statement should be included that shows that written informed consent of patients and volunteers was obtained following a detailed explanation of the procedures that they may undergo.
• For studies carried out on animals, the measures taken to prevent pain and suffering of the animals should be stated clearly.
• Information on patient consent, the name of the ethics committee, and the ethics committee approval number should also be stated in the Materials and Methods section of the manuscript.
• It is the authors’ responsibility to carefully protect the patients’ anonymity. For photographs that may reveal the identity of the patients, releases signed by the patient or their legal representative should be enclosed.